Nirav Mehta, Promoter, MD & CEO of Corona Remedies Limited said that the IPO will see a total divestment of 10.09%, of which the promoter family will sell about 3.5%, while private equity investor ChrysCapital will offload around 6.59% from its 27.5% holding.
